Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-24

FDA Approved: RANOLAZINE — Supplemental Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Ranolazine from Ajanta Pharma USA Inc., enabling updated labeling for the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranolazine (ranolazine)

Snippet

SUPPL AP for RANOLAZINE (RANOLAZINE)